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Materials
Compound I (2-methyl-oxazole) is commercially available and was purchased from J&W Pharmlab LLC (catalog No. 56R0594). Compound II (1,2-dimethy-1H-imidazol-5-ol), compound III (4-methyl-6-quinolinol), compound IV (5-methylnaphtalene-2-ol) and compound VI (1-(dimethylamino)-2,3-butanedione) were obtained from Tokyo Chemical Industry Co., Ltd. (TCI) upon custom synthesis. Compound V (N-(2-hydroxybenzyl)-Nmethylnitrous amide) was obtained from HeBei Sundia Meditech Company, Ltd. upon custom synthesis. All chemical compounds obtained by custom synthesis satisfy reagentgrade purity (> 96 %), and were used as received. Figure S11 . 1 H-NMR spectrum of compound V. This chart is measured by authors using AL300 BX NMR spectrometer (JEOL, Tokyo, Japan).
Characterization
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Figure S12.
13 C-NMR spectrum of compound V. This chart is measured by authors using AL300 BX NMR spectrometer (JEOL, Tokyo, Japan).
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Figure S13. Photograph of compound V.
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Compound VI: 1 H-NMR (in CDCl3) in ppm: 6.31 (s, 1H, C=CH), 6.2-6.0 (br, 0.5H, OH), 3.10 (s, 6H, N(CH3)2), 2.14 (s, 3H, CH3). Figure S17 . Computational UV-vis spectra for keto/enol-forms of II. 
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Compound VI Figure S24 . Experimental UV-vis absorption spectra of VI with various concentration and solvent.
